<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>31(2)</volume><submitter>Park IK</submitter><funding>NCI NIH HHS</funding><journal>Leukemia</journal><pagination>502-505</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5509909</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.</pubmed_title><pmcid>PMC5509909</pmcid><funding_grant_id>R35 CA210087</funding_grant_id><funding_grant_id>U10 CA031946</funding_grant_id><funding_grant_id>P30 CA016058</funding_grant_id><funding_grant_id>T32 CA009338</funding_grant_id><funding_grant_id>R01 CA138744</funding_grant_id><funding_grant_id>R01 CA089341</funding_grant_id><funding_grant_id>P50 CA140158</funding_grant_id><pubmed_authors>Blum W</pubmed_authors><pubmed_authors>Park IK</pubmed_authors><pubmed_authors>Baker SD</pubmed_authors><pubmed_authors>Caligiuri MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.</name><description/><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Feb</publication><modification>2025-04-04T01:27:24.916Z</modification><creation>2025-04-04T01:27:24.916Z</creation></dates><accession>S-EPMC5509909</accession><cross_references><pubmed>27773928</pubmed><doi>10.1038/leu.2016.293</doi></cross_references></HashMap>